Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

33.31USD
11:05am EDT
Change (% chg)

$0.05 (+0.17%)
Prev Close
$33.25
Open
$33.42
Day's High
$33.55
Day's Low
$33.19
Volume
1,662,912
Avg. Vol
6,873,920
52-wk High
$35.53
52-wk Low
$27.51

PFE.N

Chart for PFE.N

About

Pfizer Inc. is a global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX,... (more)

Overall

Beta: 0.74
Market Cap(Mil.): $204,742.50
Shares Outstanding(Mil.): 6,157.67
Dividend: 0.28
Yield (%): 3.37

Financials

  PFE.N Industry Sector
P/E (TTM): 23.00 35.49 39.20
EPS (TTM): 1.45 -- --
ROI: 6.44 16.99 16.19
ROE: 12.69 17.90 17.33
Search Stocks

Exclusive: Hospira wins French biosimilar drug tender at 45 pct discount

(This July 3 story corrects paragraph 10 to make clear 6 million euros refers to saving, not price)

7:46am EDT

Zoloft plaintiffs, Pfizer set to spar in second hearing on expert witnesses

- Pfizer Inc is seeking to strike a major blow to litigation over its antidepressant Zoloft by asking a federal judge, for a second time, to disqualify a key expert witness that plaintiffs say can show the drug causes birth defects.

6:55am EDT

Canada's Valeant approaches to buy Zoetis: WSJ

- Canada-based drugmaker Valeant Pharmaceuticals International Inc has approached to buy Zoetis Inc , an animal-health company, the Wall Street Journal reported.

25 Jun 2015

GSK sells two vaccines to Pfizer to ease competition concerns

LONDON - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis.

22 Jun 2015

GSK sells two vaccines to Pfizer to ease competition concerns

LONDON, June 22 - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis.

22 Jun 2015

U.S. jury clears Pfizer in second trial alleging Zoloft birth defects

NEW YORK - A U.S. jury on Thursday said Pfizer Inc was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for the company out of hundreds of similar lawsuits.

11 Jun 2015

U.S. jury clears Pfizer in second trial alleging Zoloft birth defects

NEW YORK - A U.S. jury on Thursday said Pfizer Inc was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for the company out of hundreds of similar lawsuits.

11 Jun 2015

UPDATE 2-U.S. jury clears Pfizer in second trial alleging Zoloft birth defects

NEW YORK, June 11 - A U.S. jury on Thursday said Pfizer Inc was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for the company out of hundreds of similar lawsuits.

11 Jun 2015

U.S. jury clears Pfizer in second trial over Zoloft

NEW YORK, June 11 - A U.S. jury on Thursday found Pfizer Inc not liable in a lawsuit claiming its antidepressant Zoloft caused birth defects in an eight-year old girl whose mother took the drug while pregnant, according to a company spokeswoman.

11 Jun 2015

Merck KGaA sees immunotherapy drug holding its own in cancer race

FRANKFURT - The head of Merck KGaA's healthcare division said she expected its cancer drug avelumab, jointly developed with Pfizer, to be among the first two or three to market in a field of immunotherapy pharmaceuticals that harness the power of the immune system in a range of cancer types.

01 Jun 2015

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $97.83 -0.37
Novartis AG (NOVN.VX) CHF92.75 -0.20
Merck & Co., Inc. (MRK.N) $57.31 -0.24
Roche Holding Ltd. (ROG.VX) CHF261.20 -4.20
Abbott Laboratories (ABT.N) $49.34 -0.40
Bayer AG (BAYGn.DE) €121.80 -1.40
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €86.42 -0.74
AstraZeneca plc (AZN.L) 4,186.00p +37.00
GlaxoSmithKline plc (GSK.L) 1,338.50p -3.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks